BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Iacoviello M, Leone M, Antoncecchi V, Ciccone MM. Evaluation of chronic kidney disease in chronic heart failure: From biomarkers to arterial renal resistances. World J Clin Cases 2015; 3(1): 10-19 [PMID: 25610846 DOI: 10.12998/wjcc.v3.i1.10]
URL: https://www.wjgnet.com/2307-8960/full/v3/i1/10.htm
Number Citing Articles
1
Umida Kamilova, Charos Abdullaeva, Gulnoza Zakirova, Dilyafruz Masharipova, Dilnoza Tagaeva. Assessment of Kidney Dysfunction in Patients with Chronic Heart FailureOpen Access Macedonian Journal of Medical Sciences 2022; 10(B): 2093 doi: 10.3889/oamjms.2022.10241
2
Peipei He, Congli Zhou, Huajuan Shen. Diagnostic value of phosphatidylethanolamine binding protein 4 levels in patients receiving nursing interventions for advanced chronic kidney diseaseJournal of International Medical Research 2021; 49(3): 030006052199617 doi: 10.1177/0300060521996179
3
Massimo Iacoviello, Nadia Aspromonte, Marta Leone, Valeria Paradies, Valeria Antoncecchi, Roberto Valle, Pasquale Caldarola, MarcoMatteo Ciccone, Loreto Gesualdo, Francesca Di Serio. Galectin-3 serum levels are independently associated with microalbuminuria in chronic heart failure outpatientsResearch in Cardiovascular Medicine 2016; 5(1): 12 doi: 10.5812/cardiovascmed.28952
4
E. V. Reznik, I. G. Nikitin. CARDIORENAL SYNDROME IN PATIENTS WITH CHRONIC HEART FAILURE AS A STAGE OF THE CARDIORENAL CONTINUUM (PART I): DEFINITION, CLASSIFICATION, PATHOGENESIS, DIAGNOSIS, EPIDEMIOLOGYThe Russian Archives of Internal Medicine 2019; 9(1): 5 doi: 10.20514/2226-6704-2019-9-1-5-22
5
Shihui Fu, Shaopan Zhao, Ping Ye, Leiming Luo. Biomarkers in Cardiorenal SyndromesBioMed Research International 2018; 2018: 1 doi: 10.1155/2018/9617363
6
Qian Yan, Sanfeng Chen. Hemoconcentration is a valuable predictor of prognosis in patients with acute heart failureExperimental and Therapeutic Medicine 2020;  doi: 10.3892/etm.2020.8515
7
Toshiyuki Takasu, Shoji Takakura. Effect of ipragliflozin, an SGLT2 inhibitor, on cardiac histopathological changes in a non-diabetic rat model of cardiomyopathyLife Sciences 2019; 230: 19 doi: 10.1016/j.lfs.2019.05.051
8
Ganesh V. Halade, Vasundhara Kain, Laurence M. Black, Sumanth D. Prabhu, Kevin A. Ingle. Aging dysregulates D- and E-series resolvins to modulate cardiosplenic and cardiorenal network following myocardial infarctionAging 2016; 8(11): 2611 doi: 10.18632/aging.101077
9
Harald Ihmsen, Jürgen Schüttler, Christian Jeleazcov. Pharmacokinetics of Morphine and Morphine-6-Glucuronide During Postoperative Pain Therapy in Cardiac Surgery PatientsEuropean Journal of Drug Metabolism and Pharmacokinetics 2021; 46(2): 249 doi: 10.1007/s13318-020-00663-z
10
Takahide Nawa, Kazuhiko Nishigaki, Yujiro Kinomura, Toshiki Tanaka, Yoshihisa Yamada, Masanori Kawasaki, Shinya Minatoguchi. Continuous intravenous infusion of nicorandil for 4hours before and 24hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal functionInternational Journal of Cardiology 2015; 195: 228 doi: 10.1016/j.ijcard.2015.05.078
11
Ivana Rubić, Stefan Weidt, Richard Burchmore, Alan Kovačević, Josipa Kuleš, Peter David Eckersall, Marin Torti, Ines Jović, Mislav Kovačić, Jelena Gotić, Renata Barić Rafaj, Predrag Novak, Marko Samardžija, Vladimir Mrljak. Metabolome Profiling in the Plasma of Dogs with Idiopathic Dilated Cardiomyopathy: A Multiplatform Mass-Spectrometry-Based ApproachInternational Journal of Molecular Sciences 2023; 24(20): 15182 doi: 10.3390/ijms242015182
12
Tárcio Gomes Amoras, Giovana Salomão Melo, Vitor Teixeira de Holanda, Christelaine Venzel Zaninotto, Sheila Santos de Oliveira, Fabiana de Campos Gomes, João Simão de Melo-Neto. Decompensation Factors as Predictors of Type 1 Cardiorenal Syndrome and Mortality in Patients with Acute Heart Failure: A Case-Control StudySSRN Electronic Journal 2022;  doi: 10.2139/ssrn.4189315